Last checked at 20 Apr 2017 07:00
Nanoco Group plc
("Nanoco" or the "Company")
Directorate Change
Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, is pleased to announce the appointment of Dr Alison Fielding as a Non-executive Director with effect from 20 April 2017.
Alison is Director of Strategy and IP Impact at IP Group and is currently a Non-executive Director of Getech Group plc. She holds an MBA from Manchester Business School, a PhD in organic chemistry and a first-class degree in chemistry from the University of Glasgow. Alison started her career at Zeneca PLC (now Astra Zeneca) followed by five years at McKinsey & Company and later co-founded Techtran Group Limited which was acquired by IP Group in 2005 where she held the role of director and COO until 2013. Whilst at IP Group, she also sat on the board of and advised several early stage and quoted IP Group backed technology companies.
Alison's appointment follows the announcement in January that Robin Williams would stand down as a Non-executive Director in July due to other commitments. Alison will succeed Robin as Chair of the Audit Committee on 13 July 2017. She will also be a member of the Remuneration Committee.
Dr Christopher Richards, Nanoco's Chairman, said: "Alison brings an exceptional breadth of relevant skills to the Nanoco Board, with her background in chemistry and her extensive commercial, financial and international experience across the technology sector. Her appointment will strengthen the Board significantly as we move forward to commercial success and her extensive Board experience will also reinforce Nanoco's continued commitment to governance."
Alison has been a director of several publicly quoted companies, including Fusion IP plc, hVIVO plc, IP Group plc and Tissue Regenix Group plc.
The Company confirms that there is no additional information which is required to be disclosed under Rule 9.6.13 of the Listing Rules of the UK Listing Authority.
For further information, please contact:
Nanoco | Tel: +44 (0) 161 603 7900 | |
Michael Edelman, Chief Executive Officer | ||
David Blain, Chief Financial Officer | ||
Caroline Watson, Investor Relations Manager | Tel: + 44 (0) 7799 897357 | |
cwatson@nanocotechnologies.com | ||
Peel Hunt |
Tel: +44 (0) 20 7418 8900 | |
Adrian Trimmings | ||
George Sellar | ||
Alex Lomax | ||
MHP Communications | Tel: +44 (0) 20 3128 8100 | |
Reg Hoare / Andrew Leach / Giles Robinson / Peter Lambie | ||
Nanoco@mhpc.com |
About Nanoco Group plc
Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.
Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.